Sunday, May 24, 2026
RSS

Inside BCI

Brain-Computer Interface Industry News
Industry News Research Policy Opinion Market Moves
About Directory Glossary

Tag: m-and-a

2 articles

Market Moves

Medtronic to acquire SPR Therapeutics for $650 million as top-three neuromodulation incumbents consolidate the peripheral nerve stim category

Medtronic announced on 20 May 2026 its intent to acquire SPR Therapeutics, the maker of the Sprint percutaneous peripheral nerve stimulation system, for approximately $650 million in upfront cash. The deal is the second top-three neuromodulation acquisition of a PNS specialist in seven months, after Boston Scientific completed its $533 million purchase of Nalu Medical in January 2026.

May 21

Market Moves

Bioelectronic medicine reaches commercial inflection across four companies in two weeks

Spark Biomedical's CEO appointment on May 4 caps a fortnight of substantive bioelectronic-medicine milestones: SetPoint Medical's first multiple sclerosis pilot enrolment on April 30, ResMed's $340 million acquisition of Noctrix Health on the same day, and Nervonik's $52.5 million Series B on April 27. Together the four data points map onto a single maturation arc — growth-stage capital, late-stage trial expansion, commercial scaling, incumbent acquisition — and signal that the category is moving past early-clinical research into the operational layer where all four of those events run in parallel.

May 5